ToxicologyEmergency Medicine
Hydrofluoric Acid Exposure
Severe pain disproportionate to skin signs; calcium gluconate gel topical + intra-arterial / IV; hypocalcaemia + hypomagnesaemia + cardiac arrhythmia.
Source: TOXBASE; NPIS
Step 1 of ~2
info
Recognise — Industrial / Domestic
Hydrofluoric acid (HF) — used in glass etching, semiconductor manufacture, rust removers (domestic). Penetrates deep — calcium + magnesium chelation.
Features:
• Skin: severe deep pain disproportionate to visible erythema (can develop hours after exposure for dilute HF).
• Eye: severe pain, corneal injury.
• Inhalation: pulmonary oedema.
• Ingestion: GI burns + systemic toxicity.
Systemic toxicity (any significant exposure — even small skin area for high concentration):
• Hypocalcaemia (severe; arrhythmia).
• Hypomagnesaemia.
• Hyperkalaemia.
• Cardiac arrhythmia + arrest.
• Refractory ventricular arrhythmia.
Danger thresholds:
• <20% concentration small area: usually local + delayed pain.
• >50% any area: high systemic toxicity risk.
• Body surface >1% with high concentration: significant systemic risk.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Calcium Gluconate · Electrolyte — Calcium Supplement
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Azelaic Acid 15–20% · Topical dicarboxylic acid (anti-acne / anti-rosacea)
- Mupirocin 2% Ointment · Topical antibiotic (pseudomonic acid)
- Fusidic Acid 2% Cream · Topical antibiotic (steroidal antibiotic)
- Azelaic acid · Topical anti-acne / anti-rosacea
Pathways
- Paracetamol overdose · TOXBASE/NPIS; MHRA DSU 2012/2024; SNAP regimen (Lancet 2014); BNF
- TCA overdose · TOXBASE/NPIS; AACT/EAPCCT position statements; Resuscitation Council UK ALS
- Opioid overdose · TOXBASE/NPIS; Resuscitation Council UK; BNF
- Anticholinergic toxidrome · TOXBASE/NPIS; AACT/EAPCCT; BNF
- Benzodiazepine overdose · TOXBASE/NPIS; AACT/EAPCCT; BNF
- β-blocker overdose · TOXBASE/NPIS; AACT/EAPCCT; ESC; BNF
Decision support only. Always apply local guidelines and clinical judgement.